Bridgefront Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $354K | Sell |
9,212
-2,646
| -22% | -$102K | 0.09% | 376 |
|
|
2025
Q1 | $459K | Sell |
11,858
-4,807
| -29% | -$186K | 0.13% | 277 |
|
|
2024
Q4 | $564K | Buy |
16,665
+7,037
| +73% | +$238K | 0.19% | 169 |
|
|
2024
Q3 | $394K | Buy |
+9,628
| New | +$394K | 0.15% | 251 |
|
|
2024
Q1 | – | Sell |
-6,234
| Closed | -$231K | – | 450 |
|
|
2023
Q4 | $231K | Buy |
+6,234
| New | +$231K | 0.17% | 248 |
|
|
2023
Q1 | – | Sell |
-13,785
| Closed | -$484K | – | 487 |
|
|
2022
Q4 | $484K | Buy |
+13,785
| New | +$484K | 0.34% | 106 |
|
|
2021
Q3 | – | Sell |
-9,928
| Closed | -$494K | – | 479 |
|
|
2021
Q2 | $494K | Buy |
+9,928
| New | +$494K | 0.19% | 176 |
|